Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Mardin, Wolf Arif ^a   Haier, Joerg ^a   Mees, Soeren Torge ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Epigenetics; Metastasis suppressor gene; Methylation; Pancreatic ductal adenocarcinoma; PDAC; Promoter

Indexed keywords

MESSENGER RNA; METASTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRMS1 GENE; CANCER CELL CULTURE; CARCINOGENESIS; CD82 GENE; CDH1 GENE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE EXPRESSION; GENE INACTIVATION; GENETIC REGULATION; GENETIC SELECTION; HPRT1 GENE; HUMAN; HUMAN CELL; IN VIVO STUDY; KISS1 GENE; MALE; MED23 GENE; METASTASIS POTENTIAL; METASTASIS SUPPRESSOR GENE; METHYLATION; MOUSE; NDRG1 GENE; NONHUMAN; PANCREAS ADENOCARCINOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PPIB GENE; PREDICTION; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIMP3 GENE; TUMOR SUPPRESSOR GENE; TXNIP GENE; ANIMAL; DNA METHYLATION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; NUDE MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; TUMOR CELL LINE;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84878242908     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-264     Document Type: Article

References (29)

1. Jemal A. Cancer statistics, 2005. CA Cancer J Clin 2005, 55(1):10-30. 10.3322/canjclin.55.1.10, 15661684.
2. Parkin DM. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
3. American gastroenterological association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999, 117(6):1463-84.
4. Pitt HA. Curative treatment for pancreatic neoplasms. Standard resection. Surg Clin North Am 1995, 75(5):891-904.
5. Raraty MG. New techniques and agents in the adjuvant therapy of pancreatic cancer. Acta Oncol 2002, 41(7-8):582-95.
6. Schneider G. Pancreatic cancer: basic and clinical aspects. Gastroenterology 2005, 128(6):1606-25. 10.1053/j.gastro.2005.04.001, 15887154.
7. Morris JPT, Wang SC, Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 2010, 10(10):683-95.
8. Hezel AF. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006, 20(10):1218-49. 10.1101/gad.1415606, 16702400.
9. Sato N, Goggins M. Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2006, 13(4):280-5. 10.1007/s00534-005-1056-2, 16858538.
10. Dammann R. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma. Oncogene 2003, 22(24):3806-12. 10.1038/sj.onc.1206582, 12802288.
11. Gerdes B. Tumor-suppressing pathways in cystic pancreatic tumors. Pancreas 2003, 26(1):42-8. 10.1097/00006676-200301000-00008, 12499916.
12. Omura N. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther 2008, 7(7):1146-56. 10.4161/cbt.7.7.6208, 2763640, 18535405.
13. Perini MV. Clinical and pathologic prognostic factors for curative resection for pancreatic cancer. HPB (Oxford) 2008, 10(5):356-62.
14. Raptis DA. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Surgeon 2010, 8(5):239-46. 10.1016/j.surge.2010.03.001, 20709279.
15. Peng DF. Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci 2005, 96(7):403-8. 10.1111/j.1349-7006.2005.00071.x, 16053511.
16. Fukushima N. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice. Cancer Biol Ther 2003, 2(1):78-83.
17. Park JK. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. Pancreas 2012, 41(1):95-101. 10.1097/MPA.0b013e318221c903, 21778928.
18. Park JK. Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer. Pancreas 2007, 35(3):e9-15. 10.1097/MPA.0b013e318153fa42, 17895837.
19. Pfeifer GP, Dammann R. Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry (Mosc) 2005, 70(5):576-83.
20. Matsubayashi H. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Clin Cancer Res 2003, 9(4):1446-52.
21. Jiao L. K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. Pancreas 2007, 34(1):55-62. 10.1097/01.mpa.0000246665.68869.d4, 1905887, 17198183.
22. Stafford LJ, Vaidya KS, Welch DR. Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 2008, 40(5):874-91. 10.1016/j.biocel.2007.12.016, 18280770.
23. Shevde LA, Welch DR. Metastasis suppressor pathways-an evolving paradigm. Cancer Lett 2003, 198(1):1-20. 10.1016/S0304-3835(03)00304-5, 12893425.
24. Mees ST. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol 2009, 16(8):2339-50. 10.1245/s10434-009-0531-4, 19475450.
25. Hotz HG. An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer. Pancreas 2003, 26(4):e89-98. 10.1097/00006676-200305000-00020, 12717279.
26. Mardin WA. SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma. BMC Cancer 2010, 10:549. 10.1186/1471-2407-10-549, 2966466, 20939879.
27. Vandesompele J. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome biology 2002, 3(7):RESEARCH0034. 126239, 12184808.
28. Hurst DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009, 69(4):1279-83. 10.1158/0008-5472.CAN-08-3559, 2754225, 19190326.
29. Szafranska AE. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26(30):4442-52. 10.1038/sj.onc.1210228, 17237814.